Neurogene (Neurogene) Construction In Progress : $0.23 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Neurogene Construction In Progress?

Neurogene's quarterly construction in progress stayed the same from Sep. 2023 ($0.23 Mil) to Dec. 2023 ($0.23 Mil) but then declined from Dec. 2023 ($0.23 Mil) to Mar. 2024 ($0.23 Mil).

Neurogene's annual construction in progress declined from Dec. 2021 ($2.86 Mil) to Dec. 2022 ($0.25 Mil) and declined from Dec. 2022 ($0.25 Mil) to Dec. 2023 ($0.23 Mil).

Neurogene Construction In Progress Historical Data

The historical data trend for Neurogene's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurogene Construction In Progress Chart

Neurogene Annual Data

Trend

Dec21

Dec22

Dec23

Construction In Progress

2.86

0.25

0.23

Neurogene Quarterly Data
	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial			-	0.23	0.23	0.23	0.23

Neurogene Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Neurogene (Neurogene) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

535 W 24th Street, 5th Floor, New York, NY, USA, 10011

Website

https://www.neurogene.com

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Neurogene (Neurogene) Headlines

From GuruFocus

Neurogene Announces Business Update and 2024 Outlook

By Business Wire • 01-05-2024

Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million

By Business Wire • 12-19-2023